Chapter/Section Purchase

1 Study Coverage
1.1 Acne Vulgaris Treatment Revenue in Acne Vulgaris Treatment Business (2017-2022) & (US$ Million) Introduction
1.2 Global Acne Vulgaris Treatment Outlook 2017 VS 2022 VS 2028
1.2.1 Global Acne Vulgaris Treatment Market Size for the Year 2017-2028
1.2.2 Global Acne Vulgaris Treatment Market Size for the Year 2017-2028
1.3 Acne Vulgaris Treatment Market Size, United States VS Global, 2017 VS 2022 VS 2028
1.3.1 The Market Share of United States Acne Vulgaris Treatment in Global, 2017 VS 2022 VS 2028
1.3.2 The Growth Rate of Acne Vulgaris Treatment Market Size, United States VS Global, 2017 VS 2022 VS 2028
1.4 Acne Vulgaris Treatment Market Dynamics
1.4.1 Acne Vulgaris Treatment Industry Trends
1.4.2 Acne Vulgaris Treatment Market Drivers
1.4.3 Acne Vulgaris Treatment Market Challenges
1.4.4 Acne Vulgaris Treatment Market Restraints
1.5 Study Objectives
1.6 Years Considered
2 Acne Vulgaris Treatment by Type
2.1 Acne Vulgaris Treatment Market Segment by Type
2.1.1 CB-0601
2.1.2 CJM-112
2.1.3 CLS-007
2.1.4 Dapsone
2.1.5 DFD-10
2.1.6 DLX-2323
2.1.7 Others
2.2 Global Acne Vulgaris Treatment Market Size by Type (2017, 2022 & 2028)
2.3 Global Acne Vulgaris Treatment Market Size by Type (2017-2028)
2.4 United States Acne Vulgaris Treatment Market Size by Type (2017, 2022 & 2028)
2.5 United States Acne Vulgaris Treatment Market Size by Type (2017-2028)
3 Acne Vulgaris Treatment by Application
3.1 Acne Vulgaris Treatment Market Segment by Application
3.1.1 Clinic
3.1.2 Hospital
3.1.3 Others
3.2 Global Acne Vulgaris Treatment Market Size by Application (2017, 2022 & 2028)
3.3 Global Acne Vulgaris Treatment Market Size by Application (2017-2028)
3.4 United States Acne Vulgaris Treatment Market Size by Application (2017, 2022 & 2028)
3.5 United States Acne Vulgaris Treatment Market Size by Application (2017-2028)
4 Global Acne Vulgaris Treatment Competitor Landscape by Company
4.1 Global Acne Vulgaris Treatment Market Size by Company
4.1.1 Top Global Acne Vulgaris Treatment Companies Ranked by Revenue (2021)
4.1.2 Global Acne Vulgaris Treatment Revenue by Player (2017-2022)
4.2 Global Acne Vulgaris Treatment Concentration Ratio (CR)
4.2.1 Acne Vulgaris Treatment Market Concentration Ratio (CR) (2017-2022)
4.2.2 Global Top 5 and Top 10 Largest Companies of Acne Vulgaris Treatment in 2021
4.2.3 Global Acne Vulgaris Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.3 Global Acne Vulgaris Treatment Headquarters, Revenue in Acne Vulgaris Treatment Business (2017-2022) & (US$ Million) Type
4.3.1 Global Acne Vulgaris Treatment Headquarters and Area Served
4.3.2 Global Acne Vulgaris Treatment Companies Revenue in Acne Vulgaris Treatment Business (2017-2022) & (US$ Million) Type
4.3.3 Date of International Companies Enter into Acne Vulgaris Treatment Market
4.4 Companies Mergers & Acquisitions, Expansion Plans
4.5 United States Acne Vulgaris Treatment Market Size by Company
4.5.1 Top Acne Vulgaris Treatment Players in United States, Ranked by Revenue (2021)
4.5.2 United States Acne Vulgaris Treatment Revenue by Players (2020, 2021 & 2022)
5 Global Acne Vulgaris Treatment Market Size by Region
5.1 Global Acne Vulgaris Treatment Market Size by Region: 2017 VS 2022 VS 2028
5.2 Global Acne Vulgaris Treatment Market Size by Region (2017-2028)
5.2.1 Global Acne Vulgaris Treatment Market Size by Region: 2017-2022
5.2.2 Global Acne Vulgaris Treatment Market Size by Region (2023-2028)
6 Segment in Region Level & Country Level
6.1 North America
6.1.1 North America Acne Vulgaris Treatment Market Size YoY Growth 2017-2028
6.1.2 North America Acne Vulgaris Treatment Market Facts & Figures by Country (2017, 2022 & 2028)
6.1.3 U.S.
6.1.4 Canada
6.2 Asia-Pacific
6.2.1 Asia-Pacific Acne Vulgaris Treatment Market Size YoY Growth 2017-2028
6.2.2 Asia-Pacific Acne Vulgaris Treatment Market Facts & Figures by Region (2017, 2022 & 2028)
6.2.3 China
6.2.4 Japan
6.2.5 South Korea
6.2.6 India
6.2.7 Australia
6.2.8 Taiwan
6.2.9 Indonesia
6.2.10 Thailand
6.2.11 Malaysia
6.2.12 Philippines
6.3 Europe
6.3.1 Europe Acne Vulgaris Treatment Market Size YoY Growth 2017-2028
6.3.2 Europe Acne Vulgaris Treatment Market Facts & Figures by Country (2017, 2022 & 2028)
6.3.3 Germany
6.3.4 France
6.3.5 U.K.
6.3.6 Italy
6.3.7 Russia
6.4 Latin America
6.4.1 Latin America Acne Vulgaris Treatment Market Size YoY Growth 2017-2028
6.4.2 Latin America Acne Vulgaris Treatment Market Facts & Figures by Country (2017, 2022 & 2028)
6.4.3 Mexico
6.4.4 Brazil
6.4.5 Argentina
6.5 Middle East and Africa
6.5.1 Middle East and Africa Acne Vulgaris Treatment Market Size YoY Growth 2017-2028
6.5.2 Middle East and Africa Acne Vulgaris Treatment Market Facts & Figures by Country (2017, 2022 & 2028)
6.5.3 Turkey
6.5.4 Saudi Arabia
6.5.5 U.A.E
7 Company Profiles
7.1 Common Pharma Inc
7.1.1 Common Pharma Inc Company Details
7.1.2 Common Pharma Inc Business Overview
7.1.3 Common Pharma Inc Acne Vulgaris Treatment Introduction
7.1.4 Common Pharma Inc Revenue in Acne Vulgaris Treatment Business (2017-2022)
7.1.5 Common Pharma Inc Recent Development
7.2 Cutanea Life Sciences Inc
7.2.1 Cutanea Life Sciences Inc Company Details
7.2.2 Cutanea Life Sciences Inc Business Overview
7.2.3 Cutanea Life Sciences Inc Acne Vulgaris Treatment Introduction
7.2.4 Cutanea Life Sciences Inc Revenue in Acne Vulgaris Treatment Business (2017-2022)
7.2.5 Cutanea Life Sciences Inc Recent Development
7.3 Dermira Inc
7.3.1 Dermira Inc Company Details
7.3.2 Dermira Inc Business Overview
7.3.3 Dermira Inc Acne Vulgaris Treatment Introduction
7.3.4 Dermira Inc Revenue in Acne Vulgaris Treatment Business (2017-2022)
7.3.5 Dermira Inc Recent Development
7.4 ELORAC Inc
7.4.1 ELORAC Inc Company Details
7.4.2 ELORAC Inc Business Overview
7.4.3 ELORAC Inc Acne Vulgaris Treatment Introduction
7.4.4 ELORAC Inc Revenue in Acne Vulgaris Treatment Business (2017-2022)
7.4.5 ELORAC Inc Recent Development
7.5 Ensol Biosciences Inc
7.5.1 Ensol Biosciences Inc Company Details
7.5.2 Ensol Biosciences Inc Business Overview
7.5.3 Ensol Biosciences Inc Acne Vulgaris Treatment Introduction
7.5.4 Ensol Biosciences Inc Revenue in Acne Vulgaris Treatment Business (2017-2022)
7.5.5 Ensol Biosciences Inc Recent Development
7.6 Foamix Pharmaceuticals Ltd
7.6.1 Foamix Pharmaceuticals Ltd Company Details
7.6.2 Foamix Pharmaceuticals Ltd Business Overview
7.6.3 Foamix Pharmaceuticals Ltd Acne Vulgaris Treatment Introduction
7.6.4 Foamix Pharmaceuticals Ltd Revenue in Acne Vulgaris Treatment Business (2017-2022)
7.6.5 Foamix Pharmaceuticals Ltd Recent Development
7.7 Galderma SA
7.7.1 Galderma SA Company Details
7.7.2 Galderma SA Business Overview
7.7.3 Galderma SA Acne Vulgaris Treatment Introduction
7.7.4 Galderma SA Revenue in Acne Vulgaris Treatment Business (2017-2022)
7.7.5 Galderma SA Recent Development
7.8 GlaxoSmithKline Plc
7.8.1 GlaxoSmithKline Plc Company Details
7.8.2 GlaxoSmithKline Plc Business Overview
7.8.3 GlaxoSmithKline Plc Acne Vulgaris Treatment Introduction
7.8.4 GlaxoSmithKline Plc Revenue in Acne Vulgaris Treatment Business (2017-2022)
7.8.5 GlaxoSmithKline Plc Recent Development
7.9 Helix BioMedix Inc
7.9.1 Helix BioMedix Inc Company Details
7.9.2 Helix BioMedix Inc Business Overview
7.9.3 Helix BioMedix Inc Acne Vulgaris Treatment Introduction
7.9.4 Helix BioMedix Inc Revenue in Acne Vulgaris Treatment Business (2017-2022)
7.9.5 Helix BioMedix Inc Recent Development
7.10 Hovione FarmaCiencia SA
7.10.1 Hovione FarmaCiencia SA Company Details
7.10.2 Hovione FarmaCiencia SA Business Overview
7.10.3 Hovione FarmaCiencia SA Acne Vulgaris Treatment Introduction
7.10.4 Hovione FarmaCiencia SA Revenue in Acne Vulgaris Treatment Business (2017-2022)
7.10.5 Hovione FarmaCiencia SA Recent Development
7.11 Lee's Pharmaceutical Holdings Ltd
7.11.1 Lee's Pharmaceutical Holdings Ltd Company Details
7.11.2 Lee's Pharmaceutical Holdings Ltd Business Overview
7.11.3 Lee's Pharmaceutical Holdings Ltd Acne Vulgaris Treatment Introduction
7.11.4 Lee's Pharmaceutical Holdings Ltd Revenue in Acne Vulgaris Treatment Business (2017-2022)
7.11.5 Lee's Pharmaceutical Holdings Ltd Recent Development
7.12 LEO Pharma A/S
7.12.1 LEO Pharma A/S Company Details
7.12.2 LEO Pharma A/S Business Overview
7.12.3 LEO Pharma A/S Acne Vulgaris Treatment Introduction
7.12.4 LEO Pharma A/S Revenue in Acne Vulgaris Treatment Business (2017-2022)
7.12.5 LEO Pharma A/S Recent Development
7.13 Novabiotics Ltd
7.13.1 Novabiotics Ltd Company Details
7.13.2 Novabiotics Ltd Business Overview
7.13.3 Novabiotics Ltd Acne Vulgaris Treatment Introduction
7.13.4 Novabiotics Ltd Revenue in Acne Vulgaris Treatment Business (2017-2022)
7.13.5 Novabiotics Ltd Recent Development
7.14 Novan Inc
7.14.1 Novan Inc Company Details
7.14.2 Novan Inc Business Overview
7.14.3 Novan Inc Acne Vulgaris Treatment Introduction
7.14.4 Novan Inc Revenue in Acne Vulgaris Treatment Business (2017-2022)
7.14.5 Novan Inc Recent Development
7.15 Novartis AG
7.15.1 Novartis AG Company Details
7.15.2 Novartis AG Business Overview
7.15.3 Novartis AG Acne Vulgaris Treatment Introduction
7.15.4 Novartis AG Revenue in Acne Vulgaris Treatment Business (2017-2022)
7.15.5 Novartis AG Recent Development
7.16 Paratek Pharmaceuticals Inc
7.16.1 Paratek Pharmaceuticals Inc Company Details
7.16.2 Paratek Pharmaceuticals Inc Business Overview
7.16.3 Paratek Pharmaceuticals Inc Acne Vulgaris Treatment Introduction
7.16.4 Paratek Pharmaceuticals Inc Revenue in Acne Vulgaris Treatment Business (2017-2022)
7.16.5 Paratek Pharmaceuticals Inc Recent Development
7.17 Pfizer Inc
7.17.1 Pfizer Inc Company Details
7.17.2 Pfizer Inc Business Overview
7.17.3 Pfizer Inc Acne Vulgaris Treatment Introduction
7.17.4 Pfizer Inc Revenue in Acne Vulgaris Treatment Business (2017-2022)
7.17.5 Pfizer Inc Recent Development
7.18 Phosphagenics Ltd
7.18.1 Phosphagenics Ltd Company Details
7.18.2 Phosphagenics Ltd Business Overview
7.18.3 Phosphagenics Ltd Acne Vulgaris Treatment Introduction
7.18.4 Phosphagenics Ltd Revenue in Acne Vulgaris Treatment Business (2017-2022)
7.18.5 Phosphagenics Ltd Recent Development
8 Research Findings and Conclusion
9 Appendix
9.1 Research Methodology
9.1.1 Methodology/Research Approach
9.1.2 Data Source
9.2 Author Details
9.3 Disclaimer